Results 291 to 295 of about 235,111 (295)
Some of the next articles are maybe not open access.

COVID-19 and Its Implications for Thrombosis and Anticoagulation

Seminars in Respiratory and Critical Care Medicine, 2021
Venous thromboembolism, occlusion of dialysis catheters, circuit thrombosis in extracorporeal membrane oxygenation (ECMO) devices, acute limb ischemia, and isolated strokes, all in the face of prophylactic and even therapeutic anticoagulation, are ...
S. Berkman, V. Tapson
semanticscholar   +1 more source

Anticoagulation and Transjugular Intrahepatic Portosystemic Shunt for the Management of Portal Vein Thrombosis in Cirrhosis: A Prospective Observational Study

American Journal of Gastroenterology, 2021
INTRODUCTION: Current guidelines recommend anticoagulation as the mainstay of portal vein thrombosis (PVT) treatment in cirrhosis. However, because of the heterogeneity of PVT, anticoagulation alone does not always achieve satisfactory results.
Yong Lv   +16 more
semanticscholar   +1 more source

Evaluation of Bivalirudin As an Alternative to Heparin for Systemic Anticoagulation in Pediatric Extracorporeal Membrane Oxygenation*

Pediatric Critical Care Medicine, 2020
Objectives: Heparin is the universal anticoagulant for patients receiving extracorporeal membrane oxygenation support. However, heparin has many disadvantages, especially in young children, who develop heparin resistance.
M. Hamzah   +3 more
semanticscholar   +1 more source

Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.

Journal of the American Medical Association (JAMA), 2001
A. Go   +6 more
semanticscholar   +1 more source

Portal vein thrombosis: yes or no on anticoagulation therapy

Current Opinion in Organ Transplantation, 2018
Fanny Turon   +2 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy